Jae Yoon Jeon

Jae Yoon Jeon's work centers on drug development and pharmacology, particularly small-molecule kinase inhibitors and RNA-based (siRNA) therapeutics used to treat conditions such as leukemia and liver diseases like fatty liver disease (MAFLD/MASH). Recent publications emphasize pharmacokinetics and pharmacodynamics—how drugs move through and act on the body—including clinical trial data on siRNA drugs targeting the PNPLA3 gene. This research bridges laboratory drug discovery and early-phase human clinical testing.

Publications were fairly steady at 3-4 per year from 2017-2022, followed by a gap in 2023 and a lower, less consistent output through 2024-2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026